Abstract
The purpose of this research is to study the outcomes of splenectomy for chronic and persistent immune thrombocytopenia (ITP). This study is a retrospective analysis of 254 patients with chronic or persistent ITP who underwent splenectomy at CMC, Vellore, India between 1995 and 2009. Responses were assessed based on standard criteria. One hundred and sixty seven adults and 87 children with a median age of 29 years (range 2–64) with persistent (n = 103) or chronic ITP (n = 151) was studied. Response was seen in 229 (90.2 %) including CR in 74.4 % at a median time of 1 day (range 1–54). Infections following splenectomy were reported in 16 %. Deaths related to post splenectomy sepsis occurred in 1.57 % and major bleeding in 0.78 %. At median follow-up of 54.3 months (range 1–290), 178 (70.1 %) remain in remission. The 5-year and 10-year overall survival (OS) is 97.4 ± 1.2 % and 94.9 ± 2.1 %, respectively, while the 5-year and 10-year event-free survival (EFS) is 76.5 + 2.9 % and 71.0 + 3.9 %, respectively. Splenectomy is associated with long-term remission rates of >70 % in chronic or persistent ITP.
Similar content being viewed by others
References
Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346(13):995–1008
Neunert C, Lim W, Crowther M et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190–207
Berchtold P, McMillan R (1989) Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood 74(7):2309–17
Gibson M, Sehon JK, White S et al (2000) Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review. Am Surg 66(10):952–4
Ben-Yehuda D, Gillis S, Eldor A (1994) Clinical and therapeutic experience in 712 Israeli patients with idiopathic thrombocytopenic purpura. Israeli ITP Study Group. Acta Haematol 91(1):1–6
Katkhouda N, Hurwitz MB, Rivera RT et al (1998) Laparoscopic splenectomy: outcome and efficacy in 103 consecutive patients. Ann Surg 228(4):568–78
Louwes H, Vellenga E, Houwerzijl EJ, de Wolf JT (2001) Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission. Ann Hematol 80(12):728–32
Pizzuto J, Ambriz R (1984) Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: multicentric trial of the cooperative Latin American group on hemostasis and thrombosis. Blood 64(6):1179–83
Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386–93
Kumar S, Diehn FE, Gertz MA, Tefferi A (2002) Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses. Annals Haematol 81(6):312–9
Fabris F, Tassan T, Ramon R et al (2001) Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura. Br J Haematol 112(3):637–40
Winde G, Schmid KW, Lugering N et al (1996) Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura. J Am Coll Surg 183(6):565–74
Aleem A (2011) Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients. Platelets 22(1):1–7
Kojouri K, Vesely SK, Terrell DR, George JN (2004) Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 104(9):2623–34
Shojaiefard A, Mousavi SA, Faghihi SH, Abdollahzade S (2008) Prediction of response to splenectomy in patients with idiopathic thrombocytopenic purpura. World J Surg 32(3):488–93
Fenaux P, Caulier MT, Hirschauer MC et al (1989) Reevaluation of the prognostic factors for splenectomy in chronic idiopathic thrombocytopenic purpura (ITP): a report on 181 cases. Eur J Haematol 42(3):259–64
Bourgeois E, Caulier MT, Delarozee C et al (2003) Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis. Br J Haematol 120(6):1079–88
Erh-Hao L, Chakravarty DK, Ta-Sen Y et al (2013) Long-term relapse free survival rate and predictive factors of idiopathic thrombocytopenic purpura in adults undergoing splenectomy. Biomed J 36:23–27
Qu Y, Xu J, Jiao C, Cheng Z, Ren S (2014) Long-term outcomes of laparoscopic splenectomy versus open splenectomy for idiopathic thrombocytopenic purpura. Int Surg 99(3):286–90
Vecchio R, Marchese S, Intagliata E et al (2013) Long term results after splenectomy in adult idiopathic thrombocytopenic purpura: comparison between open and laparoscopic procedures. J Laparoendosc Adv Surg Tech 23(3):192–8
Vianelli N, Palandri F, Polverelli N (2013) Splenectomyasa curative treatment for immune thrombocytopenia:a retrospective analysis of 233 patients with a minimum follow up of 10 years. Haematologica 98(6):875–880
Schwartz J, Leber MD, Gillis S et al (2003) Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol 72(2):94–8
Vianelli N, Galli M, de Vivo A, Intermesoli T et al (2005) Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases. Haematologica 90(1):72–7
Thompson RL, Moore RA, Hess CE et al (1972) Idiopathic thrombocytopenic purpura. Long-term results of treatment and the prognostic significance of response to corticosteroids. Arch Intern Med 130(5):730–4
Moulis G, Sailler L, Sommet A et al (2014) Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia; an adjusted comparison of mortality and morbidity. Am J Hematol 89:41–46
Ghanima W, Godeau B, Cines DB, Bussel JB (2012) How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood 120(5):960–969
Acknowledgments
There are no funding sources for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the local institutional review board.
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Ahmed, R., Devasia, A.J., Viswabandya, A. et al. Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children. Ann Hematol 95, 1429–1434 (2016). https://doi.org/10.1007/s00277-016-2738-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-016-2738-3